You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hemophagocytic lymphohistiocytosis (HLH)

Showing 1 - 25 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

Recruiting
  • Hemophagocytic Lymphohistiocytoses
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Oct 25, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

    Withdrawn
    • Hemophagocytic Lymphohistiocytosis
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 11, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

    Not yet recruiting
    • Hemophagocytic Lymphohistiocytosis
    • L-DEP and PD-1 antibody
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Apr 19, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

    Recruiting
    • Hemophagocytic Lymphohistiocytosis
    • DEP combine with PD-1 antibody
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Feb 13, 2022

    Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

    Not yet recruiting
    • Refractory
    • +2 more
    • GTP regimen
    • (no location specified)
    Sep 8, 2023

    Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

    Not yet recruiting
    • Carbapenem Resistant Bacterial Infection
    • Hemophagocytic Lymphohistiocytoses
    • Carrimycin tablets
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 4, 2023

    Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

    Not yet recruiting
    • Hemophagocytic Lymphohistiocytoses
    • +2 more
    • observational
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Dec 22, 2022

    IFN? and Inflammatory Mediators in Hemophagocytic

    Completed
    • Hemophagocytic Lymphohistiocytoses
    • Blood Draws Data Collection
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Sep 14, 2023

    Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

    Recruiting
    • Hemophagocytic Lymphohistiocytosis
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Sep 15, 2022

    Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

    Not yet recruiting
    • Haemophagocytic Lymphohistiocytosis
    • (no location specified)
    Feb 28, 2023

    Assessing the Presence of CT-DNA in Lymphoma Associated HLH

    Not yet recruiting
    • Lymphoma
    • Haemophagocytic Lymphohistiocytosis
      • (no location specified)
      Jan 25, 2023

      Prospective Validation of the OHI Index

      Recruiting
      • HLH
      • +4 more
        • Kfar Saba, Israel
        • +1 more
        May 21, 2023

        Segmental Resection Combined With DEP Regimen for EBV-HLH

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • +2 more
        • Segmental bowel resection combined with the DEP regimen
        • Beijing, Beijing, China
          Zhao Wang
        Nov 9, 2023

        PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • PD-1 Antibody
        • +3 more
        • L-DEP and PD-1 antibody
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Mar 8, 2023

        Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • No intervention
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        May 2, 2023

        Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

        Recruiting
        • Hemophagocytic Syndrome
        • Chongqing, China
          The Second affiliated Hosptial of Chongqing medical University
        Jun 28, 2023

        Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • Lymphoma
        • cytokine
        • Beijing, Beijing, China
          Zhao Wang
        Oct 27, 2022

        Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • Rituximab Monotherapy
        • Beijing, China
          Zhao Wang
        May 18, 2022

        Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

        Completed
        • Hemophagocytic Lymphohistiocytosis (HLH)
        • Paris, France
          Hôpital Necker-Enfants Malades
        Apr 13, 2021

        HLH Trial in Beijing (Zanubrutinib)

        Recruiting
        • HLH
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Apr 2, 2022

        Lymphoma-associated Hemophagocytic Lymphohistiocytosis

        Recruiting
        • Lymphoma
        • Hemophagocytic Lymphohistiocytoses
          • Birmingham, Alabama
            University of Alabama at Birmingham
          Jun 1, 2023

          Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)

          Recruiting
          • Chidamide
          • Hemophagocytic Lymphohistiocytosis
          • Chidamide combines with VP-16 and methylprednisolone
          • Beijing, Beijing, China
            Beijing Friendship Hospital
          Nov 29, 2021

          EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

          Recruiting
          • EBV-associated Hemophagocytic Lymphohistiocytosis
          • EBV Infection
          • EBV-TCR-T cells
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Nov 12, 2023

          Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

          Completed
          Has Results
          • Macrophage Activation Syndrome
          • +3 more
          • Cincinnati, Ohio
          • +4 more
          May 16, 2022

          EBV Infection Trial in Beijing (PD1 antibody, lenalidomide)

          Recruiting
          • EBV Infection
          • Beijing, Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Jan 4, 2022